276 related articles for article (PubMed ID: 8457884)
1. Clinicopathological features of primary lateral sclerosis are different from amyotrophic lateral sclerosis.
Hudson AJ; Kiernan JA; Munoz DG; Pringle CE; Brown WF; Ebers GC
Brain Res Bull; 1993; 30(3-4):359-64. PubMed ID: 8457884
[TBL] [Abstract][Full Text] [Related]
2. "Switchboard" malfunction in motor neuron diseases: Selective pathology of thalamic nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis.
Chipika RH; Finegan E; Li Hi Shing S; McKenna MC; Christidi F; Chang KM; Doherty MA; Hengeveld JC; Vajda A; Pender N; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O; Bede P
Neuroimage Clin; 2020; 27():102300. PubMed ID: 32554322
[TBL] [Abstract][Full Text] [Related]
3. Frontal lobe atrophy in motor neuron diseases.
Kiernan JA; Hudson AJ
Brain; 1994 Aug; 117 ( Pt 4)():747-57. PubMed ID: 7922462
[TBL] [Abstract][Full Text] [Related]
4. Corticomotoneuronal connections in primary lateral sclerosis (PLS).
Weber M; Stewart H; Hirota N; Eisen A
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Dec; 3(4):190-8. PubMed ID: 12710508
[TBL] [Abstract][Full Text] [Related]
5. Motor-evoked responses in primary lateral sclerosis.
Brown WF; Ebers GC; Hudson AJ; Pringle CE; Veitch J
Muscle Nerve; 1992 May; 15(5):626-9. PubMed ID: 1584255
[TBL] [Abstract][Full Text] [Related]
6. The motor cortex and amyotrophic lateral sclerosis.
Eisen A; Weber M
Muscle Nerve; 2001 Apr; 24(4):564-73. PubMed ID: 11268031
[TBL] [Abstract][Full Text] [Related]
7. [An autopsied case of dominantly affecting upper motor neuron with atrophy of the frontal and temporal lobes--with special reference to primary lateral sclerosis].
Konagaya M; Sakai M; Iida M; Hashizume Y
Rinsho Shinkeigaku; 1995 Apr; 35(4):384-90. PubMed ID: 7614764
[TBL] [Abstract][Full Text] [Related]
8. Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis.
Kiernan JA; Hudson AJ
Brain; 1991 Apr; 114 ( Pt 2)():843-53. PubMed ID: 2043953
[TBL] [Abstract][Full Text] [Related]
9. Diffusion tensor imaging and quantitative susceptibility mapping as diagnostic tools for motor neuron disorders.
Weidman EK; Schweitzer AD; Niogi SN; Brady EJ; Starikov A; Askin G; Shahbazi M; Wang Y; Lange D; Tsiouris AJ
Clin Imaging; 2019; 53():6-11. PubMed ID: 30286313
[TBL] [Abstract][Full Text] [Related]
10. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.
Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC
J Neurol; 2018 Aug; 265(8):1819-1828. PubMed ID: 29868980
[TBL] [Abstract][Full Text] [Related]
11. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
Iwata NK
Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
[TBL] [Abstract][Full Text] [Related]
12. Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis.
Schweitzer AD; Liu T; Gupta A; Zheng K; Seedial S; Shtilbans A; Shahbazi M; Lange D; Wang Y; Tsiouris AJ
AJR Am J Roentgenol; 2015 May; 204(5):1086-92. PubMed ID: 25905946
[TBL] [Abstract][Full Text] [Related]
13. Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study.
Bede P; Chipika RH; Finegan E; Li Hi Shing S; Doherty MA; Hengeveld JC; Vajda A; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O
Neuroimage Clin; 2019; 24():102054. PubMed ID: 31711033
[TBL] [Abstract][Full Text] [Related]
14. Constant involvement of the Betz cells and pyramidal tract in amyotrophic lateral sclerosis with dementia: a clinicopathological study of eight autopsy cases.
Tsuchiya K; Ikeda K; Mimura M; Takahashi M; Miyazaki H; Anno M; Shiotsu H; Akabane H; Niizato K; Uchihara T; Tominaga I; Nakano I
Acta Neuropathol; 2002 Sep; 104(3):249-59. PubMed ID: 12172910
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
[TBL] [Abstract][Full Text] [Related]
16. Hyperintensity of the corticospinal tract on FLAIR: A simple and sensitive objective upper motor neuron degeneration marker in clinically verified amyotrophic lateral sclerosis.
Jin J; Hu F; Zhang Q; Jia R; Dang J
J Neurol Sci; 2016 Aug; 367():177-83. PubMed ID: 27423585
[TBL] [Abstract][Full Text] [Related]
17. The clinical and radiological profile of primary lateral sclerosis: a population-based study.
Finegan E; Chipika RH; Li Hi Shing S; Doherty MA; Hengeveld JC; Vajda A; Donaghy C; McLaughlin RL; Pender N; Hardiman O; Bede P
J Neurol; 2019 Nov; 266(11):2718-2733. PubMed ID: 31325016
[TBL] [Abstract][Full Text] [Related]
18. Motor and extra-motor gray matter integrity may underlie neurophysiologic parameters of motor function in amyotrophic lateral sclerosis: a combined voxel-based morphometry and transcranial stimulation study.
Christidi F; Karavasilis E; Velonakis G; Rentzos M; Zambelis T; Zouvelou V; Xirou S; Ferentinos P; Efstathopoulos E; Kelekis N; Evdokimidis I; Karandreas N
Brain Imaging Behav; 2018 Dec; 12(6):1730-1741. PubMed ID: 29417490
[TBL] [Abstract][Full Text] [Related]
19. Fasciculation discharge frequency in amyotrophic lateral sclerosis and related disorders.
de Carvalho M; Swash M
Clin Neurophysiol; 2016 May; 127(5):2257-62. PubMed ID: 27072098
[TBL] [Abstract][Full Text] [Related]
20. Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis.
Mezzapesa DM; D'Errico E; Tortelli R; Distaso E; Cortese R; Tursi M; Federico F; Zoccolella S; Logroscino G; Dicuonzo F; Simone IL
PLoS One; 2013; 8(11):e80748. PubMed ID: 24278317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
